Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.29 billion.
Market Cap
1.11T
Revenue
105.29B
Profits
-41.72B
PE Ratio
n/a
Profit Margin
-39.62%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.86B | -0.70% | 1,350,538 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.80B | -3.58% | 1,321,137 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 49.00B | -6.87% | 3,808,056 | 3.21B |
| 4 | ARGX | argenx SE | 48.01B | 0.95% | 497,805 | 3.68B |
| 5 | ONC | BeOne Medicines AG | 36.96B | -1.15% | 537,696 | 4.97B |
| 6 | INSM | Insmed Incorporated | 35.77B | -4.69% | 4,120,321 | 447.02M |
| 7 | BNTX | BioNTech SE | 25.64B | 2.33% | 1,107,752 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.24B | 0.22% | 2,328,111 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.65B | -1.24% | 6,174,540 | - |
| 10 | INCY | Incyte Corporation | 20.87B | -0.51% | 1,760,483 | 4.81B |
| 11 | GMAB | Genmab A/S | 20.81B | -0.90% | 1,476,199 | 3.85B |
| 12 | ROIV | Roivant Sciences Ltd. | 15.41B | 0.82% | 4,936,926 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.81B | -0.53% | 3,403,223 | 353.78M |
| 14 | IONS | Ionis Pharmaceuticals, Inc. | 13.23B | 1.69% | 1,570,546 | 966.96M |
| 15 | MRNA | Moderna, Inc. | 13.22B | -1.34% | 9,435,196 | 2.23B |
| 16 | SMMT | Summit Therapeutics Inc. | 13.14B | -13.41% | 8,787,813 | - |
| 17 | ASND | Ascendis Pharma A/S | 12.81B | 2.84% | 1,210,697 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.86B | 0.05% | 4,143,021 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.59B | -0.69% | 295,944 | 740.64M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.09B | -2.10% | 2,182,785 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.90B | -0.06% | 1,519,033 | 20.87M |
| 22 | TECH | Bio-Techne Corporation | 10.37B | 1.31% | 1,509,011 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 9.95B | 1.58% | 889,976 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.45B | 3.15% | 6,145,952 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.06B | 2.12% | 2,526,307 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.91B | 4.39% | 1,167,121 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.52B | -0.07% | 1,400,197 | 1.24B |
| 28 | CYTK | Cytokinetics, Incorporated | 7.90B | 3.41% | 1,846,070 | 87.21M |
| 29 | KRYS | Krystal Biotech, Inc. | 7.89B | 4.10% | 462,339 | 373.16M |
| 30 | NUVL | Nuvalent, Inc. | 7.70B | -5.61% | 914,753 | - |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.56B | -4.41% | 517,887 | 7.46M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.22B | -10.21% | 4,803,818 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.00B | 3.83% | 502,125 | 174.33M |
| 34 | PTCT | PTC Therapeutics, Inc. | 6.23B | 0.08% | 2,639,215 | 1.78B |
| 35 | PCVX | Vaxcyte, Inc. | 6.00B | -0.46% | 637,199 | - |
| 36 | KYMR | Kymera Therapeutics, Inc. | 5.85B | -2.25% | 785,538 | 43.74M |
| 37 | BLTE | Belite Bio, Inc | 5.83B | -1.89% | 327,303 | - |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.67B | 3.94% | 1,375,527 | 1.54M |
| 39 | COGT | Cogent Biosciences, Inc. | 5.29B | -1.67% | 1,457,941 | - |
| 40 | CRSP | CRISPR Therapeutics AG | 5.27B | 2.71% | 1,147,247 | 38.34M |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.24B | -0.44% | 915,567 | - |
| 42 | IMVT | Immunovant, Inc. | 5.23B | -0.85% | 1,155,413 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.02B | 0.04% | 739,780 | 209.22M |
| 44 | CELC | Celcuity Inc. | 4.84B | -2.79% | 605,616 | - |
| 45 | GPCR | Structure Therapeutics Inc. | 4.80B | 1.09% | 808,425 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 4.63B | 3.38% | 1,229,452 | 471.79M |
| 47 | ACAD | ACADIA Pharmaceuticals Inc. | 4.50B | -0.71% | 1,046,945 | 1.05B |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.44B | 3.27% | 1,147,076 | - |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.42B | - | 11,695,898 | 598.70M |
| 50 | LEGN | Legend Biotech Corporation | 4.38B | 0.42% | 2,078,044 | 909.05M |
| 51 | CGON | CG Oncology, Inc. | 4.33B | -0.89% | 1,899,289 | 2.17M |
| 52 | ADMA | ADMA Biologics, Inc. | 4.27B | -0.11% | 5,542,212 | 488.56M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.07B | 0.08% | 290,368 | 251.23M |
| 54 | TGTX | TG Therapeutics, Inc. | 4.05B | -2.63% | 2,833,585 | 531.90M |
| 55 | CORT | Corcept Therapeutics Incorporated | 3.93B | -0.37% | 1,325,878 | 741.17M |
| 56 | ACLX | Arcellx, Inc. | 3.75B | -2.11% | 557,782 | 35.90M |
| 57 | TERN | Terns Pharmaceuticals, Inc. | 3.71B | -3.86% | 2,497,606 | - |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 3.71B | -4.89% | 725,656 | 35.24M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.59B | -0.72% | 2,863,318 | - |
| 60 | BEAM | Beam Therapeutics Inc. | 3.32B | 22.29% | 7,051,068 | 55.70M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.30B | -4.62% | 869,748 | - |
| 62 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | -5.10% | 2,727,327 | 317.93M |
| 63 | IDYA | IDEAYA Biosciences, Inc. | 3.23B | -1.44% | 654,083 | 214.83M |
| 64 | CNTA | Centessa Pharmaceuticals plc | 3.22B | -1.78% | 514,514 | 15.00M |
| 65 | TARS | Tarsus Pharmaceuticals, Inc. | 3.21B | -1.74% | 489,429 | 366.10M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.19B | -2.18% | 1,253,699 | 7.50M |
| 67 | LQDA | Liquidia Corporation | 3.18B | 2.06% | 3,337,006 | 69.22M |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.11B | 2.65% | 1,153,082 | 70.79M |
| 69 | TVTX | Travere Therapeutics, Inc. | 3.05B | -1.39% | 3,914,020 | 435.83M |
| 70 | IRON | Disc Medicine, Inc. | 2.99B | 1.22% | 475,673 | - |
| 71 | APLS | Apellis Pharmaceuticals, Inc. | 2.94B | -15.02% | 5,258,106 | 1.02B |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.87B | -1.74% | 1,448,056 | - |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.85B | 2.20% | 1,043,215 | 578.20M |
| 74 | DNLI | Denali Therapeutics Inc. | 2.80B | 5.09% | 840,890 | - |
| 75 | ADPT | Adaptive Biotechnologies Corporation | 2.79B | 15.86% | 3,587,562 | 252.75M |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.64B | 1.38% | 1,114,571 | 240.00M |
| 77 | MLYS | Mineralys Therapeutics, Inc. | 2.61B | -1.17% | 1,586,756 | - |
| 78 | AAPG | Ascentage Pharma Group International | 2.58B | -1.39% | 1,521 | 54.52M |
| 79 | ALMS | Alumis Inc. | 2.57B | 7.82% | 4,196,364 | 22.12M |
| 80 | EWTX | Edgewise Therapeutics, Inc. | 2.55B | -3.09% | 434,077 | - |
| 81 | IBRX | ImmunityBio, Inc. | 2.55B | 11.16% | 13,132,613 | 82.56M |
| 82 | TLX | Telix Pharmaceuticals Limited | 2.55B | -0.13% | 106,010 | 664.23M |
| 83 | WVE | Wave Life Sciences Ltd. | 2.55B | 0.51% | 6,145,341 | 109.23M |
| 84 | SYRE | Spyre Therapeutics, Inc. | 2.55B | 7.15% | 581,588 | - |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.50B | 3.22% | 24,665,893 | 43.69M |
| 86 | MESO | Mesoblast Limited | 2.46B | -10.93% | 559,482 | 17.20M |
| 87 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | 8.26% | 4,596,368 | 630.60M |
| 88 | OCUL | Ocular Therapeutix, Inc. | 2.28B | -5.06% | 5,494,971 | 55.78M |
| 89 | IMNM | Immunome, Inc. | 2.27B | -2.37% | 1,820,170 | 9.68M |
| 90 | OLMA | Olema Pharmaceuticals, Inc. | 2.26B | 2.53% | 1,774,610 | - |
| 91 | SLNO | Soleno Therapeutics, Inc. | 2.23B | -3.40% | 3,473,274 | 98.68M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | -11.29% | 6,589,793 | 2.41B |
| 93 | NUVB | Nuvation Bio Inc. | 2.21B | -19.65% | 15,559,708 | 26.75M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 2.20B | -0.73% | 693,702 | 825.94M |
| 95 | GLPG | Galapagos NV | 2.16B | - | 122,070 | 336.64M |
| 96 | ZLAB | Zai Lab Limited | 2.05B | -0.86% | 419,083 | 441.63M |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | 0.86% | 858,475 | 265.81M |
| 98 | MAZE | Maze Therapeutics, Inc. | 1.93B | -0.32% | 201,793 | 2.50M |
| 99 | GLUE | Monte Rosa Therapeutics, Inc. | 1.88B | -2.31% | 2,852,444 | 181.54M |
| 100 | NRIX | Nurix Therapeutics, Inc. | 1.86B | -4.77% | 1,195,274 | 83.69M |
| 101 | VCEL | Vericel Corporation | 1.85B | -5.11% | 473,329 | 258.72M |
| 102 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | -1.33% | 1,450,907 | 111.30M |
| 103 | ARDX | Ardelyx, Inc. | 1.79B | -4.91% | 7,145,193 | 398.23M |
| 104 | MNKD | MannKind Corporation | 1.77B | -1.37% | 3,684,965 | 313.79M |
| 105 | ERAS | Erasca, Inc. | 1.77B | -7.84% | 5,773,622 | - |
| 106 | KOD | Kodiak Sciences Inc. | 1.74B | 1.23% | 806,152 | - |
| 107 | ZYME | Zymeworks Inc. | 1.73B | -0.04% | 1,062,235 | 134.48M |
| 108 | UPB | Upstream Bio, Inc. | 1.71B | 6.42% | 678,917 | 2.80M |
| 109 | CLDX | Celldex Therapeutics, Inc. | 1.71B | -6.25% | 1,060,350 | 2.60M |
| 110 | FTRE | Fortrea Holdings Inc. | 1.70B | 5.81% | 1,268,911 | 2.76B |
| 111 | PHVS | Pharvaris N.V. | 1.70B | 1.00% | 264,600 | - |
| 112 | NBY | NovaBay Pharmaceuticals, Inc. | 1.69B | -29.80% | 1,014,577 | 10.30M |
| 113 | STOK | Stoke Therapeutics, Inc. | 1.68B | -10.44% | 1,964,964 | 205.63M |
| 114 | DNTH | Dianthus Therapeutics, Inc. | 1.68B | 2.57% | 703,781 | 3.08M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | -0.32% | 904,464 | 44.79M |
| 116 | IMCR | Immunocore Holdings plc | 1.65B | -1.08% | 414,690 | 379.59M |
| 117 | MBX | MBX Biosciences, Inc. | 1.64B | 15.19% | 1,227,092 | - |
| 118 | SION | Sionna Therapeutics, Inc. | 1.62B | -7.41% | 191,324 | - |
| 119 | BHVN | Biohaven Ltd. | 1.57B | 6.57% | 6,711,133 | - |
| 120 | TYRA | Tyra Biosciences, Inc. | 1.54B | -1.77% | 434,959 | - |
| 121 | ORKA | Oruka Therapeutics, Inc. | 1.49B | 10.16% | 617,264 | - |
| 122 | ELVN | Enliven Therapeutics, Inc. | 1.49B | -3.73% | 1,373,161 | - |
| 123 | PGEN | Precigen, Inc. | 1.46B | -9.91% | 5,963,434 | 6.31M |
| 124 | INVA | Innoviva, Inc. | 1.45B | -0.77% | 804,826 | 388.52M |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.45B | 0.98% | 744,006 | - |
| 126 | TNGX | Tango Therapeutics, Inc. | 1.44B | -9.28% | 2,187,730 | 66.50M |
| 127 | QURE | uniQure N.V. | 1.44B | -9.00% | 2,772,381 | 15.75M |
| 128 | SVRA | Savara Inc. | 1.39B | -0.69% | 990,785 | - |
| 129 | MNMD | Mind Medicine (MindMed) Inc. | 1.37B | 0.29% | 2,103,923 | - |
| 130 | ATAI | AtaiBeckley Inc. | 1.37B | 0.27% | 7,053,732 | 3.02M |
| 131 | ANAB | AnaptysBio, Inc. | 1.36B | 9.76% | 673,053 | 169.47M |
| 132 | ABCL | AbCellera Biologics Inc. | 1.35B | 3.43% | 5,003,873 | 35.33M |
| 133 | RLAY | Relay Therapeutics, Inc. | 1.35B | -2.44% | 1,695,196 | 8.36M |
| 134 | OCS | Oculis Holding AG | 1.34B | 0.35% | 235,901 | 992.00K |
| 135 | TSHA | Taysha Gene Therapies, Inc. | 1.33B | -2.41% | 3,010,650 | 6.31M |
| 136 | NTLA | Intellia Therapeutics, Inc. | 1.32B | 10.12% | 6,741,790 | 57.53M |
| 137 | EYPT | EyePoint, Inc. | 1.32B | -1.79% | 829,783 | 42.34M |
| 138 | XERS | Xeris Biopharma Holdings, Inc. | 1.31B | -0.76% | 1,582,193 | 266.14M |
| 139 | MLTX | MoonLake Immunotherapeutics | 1.29B | -2.16% | 4,679,113 | - |
| 140 | RAPP | Rapport Therapeutics, Inc. | 1.29B | -6.77% | 278,605 | - |
| 141 | PHAR | Pharming Group N.V. | 1.27B | -0.64% | 41,874 | 362.27M |
| 142 | CAPR | Capricor Therapeutics, Inc. | 1.27B | 2.81% | 1,489,733 | 11.13M |
| 143 | NVAX | Novavax, Inc. | 1.26B | 6.60% | 2,950,376 | 1.06B |
| 144 | IMTX | Immatics N.V. | 1.23B | -0.11% | 345,127 | 99.45M |
| 145 | SANA | Sana Biotechnology, Inc. | 1.22B | 0.44% | 2,027,456 | - |
| 146 | PVLA | Palvella Therapeutics, Inc. | 1.19B | 8.74% | 137,240 | - |
| 147 | DAWN | Day One Biopharmaceuticals, Inc. | 1.16B | 26.73% | 8,022,032 | 133.67M |
| 148 | AKTS | Aktis Oncology, Inc. | 1.14B | -2.90% | 829,349 | 5.56M |
| 149 | PHAT | Phathom Pharmaceuticals, Inc. | 1.13B | -3.63% | 2,207,190 | 147.19M |
| 150 | SPRY | ARS Pharmaceuticals, Inc. | 1.12B | -12.86% | 3,962,475 | 142.77M |
| 151 | SEPN | Septerna, Inc. | 1.11B | -1.66% | 1,073,595 | 22.05M |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.10B | 4.23% | 200,204 | 1.40M |
| 153 | ZBIO | Zenas BioPharma, Inc. | 1.06B | 23.01% | 1,917,644 | 15.00M |
| 154 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.01B | -3.94% | 438,524 | - |
| 155 | XNCR | Xencor, Inc. | 1.01B | 2.02% | 842,308 | 150.13M |
| 156 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.01B | 0.25% | 1,355,499 | 192.44M |
| 157 | URGN | UroGen Pharma Ltd. | 1.00B | 0.94% | 512,245 | 96.52M |
| 158 | TBPH | Theravance Biopharma, Inc. | 995.71M | 3.20% | 498,572 | 80.33M |
| 159 | VTYX | Ventyx Biosciences, Inc. | 993.02M | 0.22% | 2,787,235 | - |
| 160 | IVA | Inventiva S.A. | 982.71M | 12.84% | 1,373,443 | 19.93M |
| 161 | NBTX | Nanobiotix S.A. | 974.02M | -2.29% | 31,435 | 11.93M |
| 162 | RAPT | RAPT Therapeutics, Inc. | 954.92M | 2.50% | 177,737 | - |
| 163 | BCAX | Bicara Therapeutics Inc. | 954.85M | -2.90% | 618,034 | - |
| 164 | IOVA | Iovance Biotherapeutics, Inc. | 952.72M | -2.04% | 7,080,525 | 250.43M |
| 165 | GHRS | GH Research PLC | 943.47M | 1.33% | 90,677 | - |
| 166 | CMPX | Compass Therapeutics, Inc. | 926.66M | -2.62% | 1,602,131 | 850.00K |
| 167 | GERN | Geron Corporation | 912.85M | 6.72% | 21,628,744 | 183.40M |
| 168 | OMER | Omeros Corporation | 908.94M | 2.64% | 2,161,940 | - |
| 169 | ORIC | ORIC Pharmaceuticals, Inc. | 891.11M | - | 1,247,725 | - |
| 170 | MDXG | MiMedx Group, Inc. | 888.61M | -1.64% | 728,769 | 393.44M |
| 171 | ABUS | Arbutus Biopharma Corporation | 865.46M | -2.60% | 1,008,301 | 14.61M |
| 172 | DRUG | Bright Minds Biosciences Inc. | 859.41M | 2.21% | 107,857 | - |
| 173 | VALN | Valneva SE | 850.58M | -1.11% | 17,685 | 211.09M |
| 174 | JANX | Janux Therapeutics, Inc. | 843.87M | -0.92% | 1,282,759 | 10.00M |
| 175 | AVBP | ArriVent BioPharma, Inc. | 843.79M | -0.39% | 319,443 | - |
| 176 | MPLT | MapLight Therapeutics, Inc. | 832.24M | 5.83% | 185,480 | - |
| 177 | YDES | YD Bio Limited | 831.18M | -4.21% | 52,793 | 510.36K |
| 178 | ANNX | Annexon, Inc. | 828.75M | 5.90% | 1,272,292 | - |
| 179 | KALV | KalVista Pharmaceuticals, Inc. | 828.45M | -2.44% | 1,963,745 | 1.43M |
| 180 | VIR | Vir Biotechnology, Inc. | 823.62M | 1.20% | 883,461 | 16.86M |
| 181 | KURA | Kura Oncology, Inc. | 797.95M | -2.55% | 1,517,607 | 104.03M |
| 182 | NKTR | Nektar Therapeutics | 788.64M | -2.37% | 946,486 | 62.60M |
| 183 | ARVN | Arvinas, Inc. | 780.33M | 0.66% | 738,456 | 312.30M |
| 184 | RGNX | REGENXBIO Inc. | 763.40M | 3.36% | 1,006,260 | 161.32M |
| 185 | PRME | Prime Medicine, Inc. | 757.72M | 8.63% | 4,487,447 | 5.98M |
| 186 | CTMX | CytomX Therapeutics, Inc. | 735.35M | -0.23% | 1,895,976 | 113.63M |
| 187 | DBVT | DBV Technologies S.A. | 726.28M | 5.41% | 212,394 | 5.50M |
| 188 | ATXS | Astria Therapeutics, Inc. | 726.12M | -1.24% | 771,216 | 706.00K |
| 189 | RIGL | Rigel Pharmaceuticals, Inc. | 725.33M | -2.15% | 707,491 | 282.08M |
| 190 | PROK | ProKidney Corp. | 700.94M | -0.43% | 552,499 | 744.00K |
| 191 | SLS | SELLAS Life Sciences Group, Inc. | 699.86M | 18.79% | 16,660,501 | - |
| 192 | GYRE | Gyre Therapeutics, Inc. | 699.86M | 4.05% | 45,217 | 107.27M |
| 193 | IVVD | Invivyd, Inc. | 690.87M | -2.78% | 2,913,002 | 50.04M |
| 194 | EVMN | Evommune, Inc. | 666.42M | 5.02% | 282,512 | 13.00M |
| 195 | JBIO | Jade Biosciences, Inc. | 637.62M | 2.44% | 640,005 | - |
| 196 | REPL | Replimune Group, Inc. | 635.78M | 0.93% | 1,403,804 | - |
| 197 | FULC | Fulcrum Therapeutics, Inc. | 627.38M | -3.45% | 973,599 | 80.00M |
| 198 | CGEM | Cullinan Therapeutics, Inc. | 626.80M | -2.66% | 545,765 | - |
| 199 | DRTS | Alpha Tau Medical Ltd. | 604.52M | 2.31% | 272,916 | - |
| 200 | TENX | Tenax Therapeutics, Inc. | 596.38M | 10.53% | 275,384 | - |
| 201 | LXEO | Lexeo Therapeutics, Inc. | 592.66M | -22.96% | 5,167,237 | - |
| 202 | GOSS | Gossamer Bio, Inc. | 583.27M | 0.80% | 4,239,311 | 44.05M |
| 203 | MGTX | MeiraGTx Holdings plc | 582.75M | -2.29% | 487,298 | 27.42M |
| 204 | KROS | Keros Therapeutics, Inc. | 575.20M | -1.67% | 376,466 | 246.72M |
| 205 | CRMD | CorMedix Inc. | 563.34M | -6.29% | 5,279,652 | 214.30M |
| 206 | ENGN | enGene Holdings Inc. | 555.97M | -5.79% | 199,645 | - |
| 207 | OCGN | Ocugen, Inc. | 555.93M | 18.67% | 10,163,335 | 5.37M |
| 208 | VSTM | Verastem, Inc. | 548.76M | -8.73% | 2,446,247 | 13.38M |
| 209 | VOR | Vor Biopharma Inc. | 547.89M | 4.66% | 1,133,822 | - |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 543.35M | 3.46% | 782,328 | 180.61M |
| 211 | FBRX | Forte Biosciences, Inc. | 528.88M | 24.20% | 423,366 | - |
| 212 | ANRO | Alto Neuroscience, Inc. | 526.26M | 3.48% | 135,577 | - |
| 213 | DSGN | Design Therapeutics, Inc. | 519.51M | -2.88% | 344,428 | - |
| 214 | NAGE | Niagen Bioscience, Inc. | 511.77M | -1.99% | 866,539 | 124.71M |
| 215 | ABSI | Absci Corporation | 511.26M | 1.95% | 3,596,427 | 2.82M |
| 216 | LYEL | Lyell Immunopharma, Inc. | 504.97M | -3.18% | 64,185 | 41.00K |
| 217 | CRVS | Corvus Pharmaceuticals, Inc. | 504.10M | -0.59% | 1,312,453 | - |
| 218 | LENZ | LENZ Therapeutics, Inc. | 487.18M | 4.71% | 1,047,025 | 17.50M |
| 219 | ASMB | Assembly Biosciences, Inc. | 486.69M | -3.06% | 100,154 | 37.19M |
| 220 | LBRX | LB Pharmaceuticals Inc | 481.44M | -8.20% | 222,518 | - |
| 221 | PRTA | Prothena Corporation plc | 479.63M | -3.05% | 585,586 | 11.79M |
| 222 | ADCT | ADC Therapeutics SA | 473.21M | 4.37% | 577,444 | 75.21M |
| 223 | ZVRA | Zevra Therapeutics, Inc. | 471.77M | -1.30% | 1,002,304 | 84.39M |
| 224 | KYTX | Kyverna Therapeutics, Inc. | 470.18M | -1.08% | 883,118 | - |
| 225 | BCYC | Bicycle Therapeutics plc | 456.79M | -0.83% | 506,024 | 28.34M |
| 226 | ALT | Altimmune, Inc. | 442.08M | 0.75% | 2,753,172 | 20.00K |
| 227 | VNDA | Vanda Pharmaceuticals Inc. | 437.91M | 1.09% | 1,210,497 | 212.07M |
| 228 | DMAC | DiaMedica Therapeutics Inc. | 436.13M | -0.25% | 164,944 | - |
| 229 | MNPR | Monopar Therapeutics Inc. | 434.57M | 3.22% | 328,798 | - |
| 230 | IMMP | Immutep Limited | 430.85M | 4.07% | 228,927 | 3.31M |
| 231 | PRTC | PureTech Health plc | 429.71M | 1.42% | 1,188 | 6.39M |
| 232 | NBP | NovaBridge Biosciences | 428.88M | 0.54% | 2,151,182 | - |
| 233 | LXRX | Lexicon Pharmaceuticals, Inc. | 428.81M | 0.85% | 1,735,930 | 70.86M |
| 234 | FDMT | 4D Molecular Therapeutics, Inc. | 428.51M | - | 766,975 | 120.00K |
| 235 | LCTX | Lineage Cell Therapeutics, Inc. | 426.50M | 2.92% | 1,534,948 | 10.82M |
| 236 | VTVT | vTv Therapeutics Inc. | 423.39M | -4.09% | 26,396 | 17.00K |
| 237 | BNTC | Benitec Biopharma Inc. | 411.09M | 2.53% | 181,812 | - |
| 238 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.41M | 0.99% | 75,983 | - |
| 239 | SLDB | Solid Biosciences Inc. | 408.25M | -0.95% | 1,350,028 | - |
| 240 | AUTL | Autolus Therapeutics plc | 399.21M | -17.13% | 6,757,858 | 51.13M |
| 241 | PEPG | PepGen Inc. | 390.49M | -12.21% | 848,705 | - |
| 242 | RCKT | Rocket Pharmaceuticals, Inc. | 389.60M | -3.49% | 2,484,350 | - |
| 243 | AVXL | Anavex Life Sciences Corp. | 383.30M | 0.23% | 987,375 | - |
| 244 | NMRA | Neumora Therapeutics, Inc. | 377.26M | - | 1,438,803 | - |
| 245 | ALLO | Allogene Therapeutics, Inc. | 375.30M | -2.34% | 4,279,750 | 22.00K |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 372.90M | -1.45% | 303,412 | 65.32M |
| 247 | GLSI | Greenwich LifeSciences, Inc. | 371.72M | 6.13% | 411,835 | - |
| 248 | HELP | Cybin Inc. | 368.29M | -1.99% | 387,557 | - |
| 249 | TECX | Tectonic Therapeutic, Inc. | 366.84M | -4.67% | 158,367 | - |
| 250 | FHTX | Foghorn Therapeutics Inc. | 360.80M | 23.64% | 387,166 | 24.52M |
| 251 | TRDA | Entrada Therapeutics, Inc. | 357.54M | -0.50% | 419,870 | 61.52M |
| 252 | ACIU | AC Immune SA | 348.28M | 3.23% | 322,076 | 5.48M |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 341.00M | -2.50% | 353,996 | 33.98M |
| 254 | ZURA | Zura Bio Limited | 340.07M | 2.15% | 533,429 | - |
| 255 | CTNM | Contineum Therapeutics, Inc. | 335.89M | -1.24% | 173,508 | - |
| 256 | XOMA | XOMA Royalty Corporation | 331.74M | -10.25% | 837,768 | 47.11M |
| 257 | AARD | Aardvark Therapeutics, Inc. | 323.12M | 3.99% | 399,164 | - |
| 258 | AURA | Aura Biosciences, Inc. | 321.96M | -0.39% | 139,561 | - |
| 259 | CADL | Candel Therapeutics, Inc. | 321.70M | 2.63% | 831,084 | - |
| 260 | PBYI | Puma Biotechnology, Inc. | 316.46M | 2.78% | 195,864 | 212.00M |
| 261 | CAMP | Camp4 Therapeutics Corporation | 313.36M | 1.85% | 72,340 | 3.80M |
| 262 | AVTX | Avalo Therapeutics, Inc. | 308.61M | -1.65% | 182,998 | 192.00K |
| 263 | CLLS | Cellectis S.A. | 306.18M | -3.40% | 24,857 | 82.55M |
| 264 | RLMD | Relmada Therapeutics, Inc. | 301.40M | -4.64% | 497,513 | - |
| 265 | ACHV | Achieve Life Sciences, Inc. | 301.30M | 1.80% | 680,241 | - |
| 266 | STTK | Shattuck Labs, Inc. | 290.45M | -3.37% | 899,788 | 1.00M |
| 267 | ACRS | Aclaris Therapeutics, Inc. | 288.20M | 0.76% | 1,248,963 | 15.74M |
| 268 | PALI | Palisade Bio, Inc. | 283.11M | -4.52% | 7,976,657 | - |
| 269 | AVIR | Atea Pharmaceuticals, Inc. | 282.04M | 4.64% | 307,898 | - |
| 270 | TARA | Protara Therapeutics, Inc. | 280.80M | -8.87% | 1,194,254 | - |
| 271 | LRMR | Larimar Therapeutics, Inc. | 279.02M | -2.10% | 1,761,715 | - |
| 272 | SLN | Silence Therapeutics plc | 278.68M | 6.88% | 372,514 | 25.83M |
| 273 | ABEO | Abeona Therapeutics Inc. | 276.38M | -1.73% | 1,214,542 | 400.00K |
| 274 | OABI | OmniAb, Inc. | 274.95M | - | 183,645 | 21.09M |
| 275 | GUTS | Fractyl Health, Inc. | 274.09M | - | 2,356,877 | 3.00K |
| 276 | MENS | Jyong Biotech Ltd. | 273.76M | -6.56% | 318,889 | - |
| 277 | HRTX | Heron Therapeutics, Inc. | 273.21M | 7.19% | 3,918,823 | 155.10M |
| 278 | IMRX | Immuneering Corporation | 272.49M | -9.34% | 4,413,986 | - |
| 279 | NGNE | Neurogene Inc. | 267.66M | -3.57% | 160,491 | 925.00K |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 263.13M | -2.92% | 373,787 | 2.82M |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 260.25M | -1.93% | 93,641 | 38.79M |
| 282 | NAUT | Nautilus Biotechnology, Inc. | 251.35M | -3.40% | 128,745 | - |
| 283 | ALDX | Aldeyra Therapeutics, Inc. | 248.47M | 0.49% | 617,500 | - |
| 284 | ARMP | Armata Pharmaceuticals, Inc. | 243.20M | -5.25% | 78,641 | 5.05M |
| 285 | IMMX | Immix Biopharma, Inc. | 233.97M | -8.83% | 1,540,219 | - |
| 286 | IKT | Inhibikase Therapeutics, Inc. | 233.90M | -0.29% | 672,304 | 1.00 |
| 287 | RZLT | Rezolute, Inc. | 232.75M | -4.56% | 2,686,249 | - |
| 288 | ENLV | Enlivex Therapeutics Ltd. | 226.15M | 5.66% | 555,623 | - |
| 289 | ZNTL | Zentalis Pharmaceuticals, Inc. | 225.98M | -6.68% | 6,460,651 | 26.87M |
| 290 | CLYM | Climb Bio, Inc. | 224.40M | -6.56% | 1,235,479 | - |
| 291 | MDWD | MediWound Ltd. | 220.91M | -7.86% | 252,774 | 20.93M |
| 292 | HUMA | Humacyte, Inc. | 218.09M | -3.42% | 5,470,876 | 1.57M |
| 293 | VYGR | Voyager Therapeutics, Inc. | 216.84M | -2.99% | 871,955 | 31.32M |
| 294 | CBIO | Crescent Biopharma, Inc. | 214.66M | 1.76% | 73,538 | - |
| 295 | ARCT | Arcturus Therapeutics Holdings Inc. | 213.96M | 11.06% | 1,060,948 | 97.60M |
| 296 | CABA | Cabaletta Bio, Inc. | 212.75M | 5.24% | 3,232,835 | - |
| 297 | NVCT | Nuvectis Pharma, Inc. | 210.04M | -3.07% | 67,930 | - |
| 298 | OVID | Ovid Therapeutics Inc. | 209.60M | -3.59% | 1,261,360 | 6.61M |
| 299 | EDIT | Editas Medicine, Inc. | 207.93M | 2.90% | 1,865,096 | 46.38M |
| 300 | CCCC | C4 Therapeutics, Inc. | 206.43M | -0.47% | 1,823,483 | 30.11M |
| 301 | GALT | Galectin Therapeutics Inc. | 203.73M | 0.32% | 237,042 | - |
| 302 | SGMT | Sagimet Biosciences Inc. | 202.93M | 0.48% | 799,084 | - |
| 303 | ALEC | Alector, Inc. | 200.84M | -1.08% | 1,270,739 | 69.05M |
| 304 | CHRS | Coherus Oncology, Inc. | 199.44M | -2.37% | 1,115,491 | 277.73M |
| 305 | MIST | Milestone Pharmaceuticals Inc. | 199.10M | -3.92% | 2,422,389 | - |
| 306 | TNXP | Tonix Pharmaceuticals Holding Corp. | 195.42M | 1.87% | 309,958 | 10.30M |
| 307 | CRDF | Cardiff Oncology, Inc. | 193.32M | -6.82% | 836,693 | 501.00K |
| 308 | VXRT | Vaxart, Inc. | 190.06M | 16.47% | - | 148.20M |
| 309 | RNAC | Cartesian Therapeutics, Inc. | 189.05M | -11.34% | 162,962 | 1.09M |
| 310 | NTHI | NeOnc Technologies Holdings, Inc. | 187.93M | -3.50% | 46,299 | 59.99K |
| 311 | NERV | Minerva Neurosciences, Inc. | 186.95M | -2.92% | 69,987 | - |
| 312 | CGEN | Compugen Ltd. | 185.20M | 5.32% | 1,174,545 | 6.90M |
| 313 | PRLD | Prelude Therapeutics Incorporated | 181.27M | -16.35% | 1,466,397 | 10.50M |
| 314 | RANI | Rani Therapeutics Holdings, Inc. | 181.07M | 6.43% | 2,557,408 | 1.20M |
| 315 | IPSC | Century Therapeutics, Inc. | 178.12M | 5.15% | 2,481,583 | 113.34M |
| 316 | SABS | SAB Biotherapeutics, Inc. | 178.05M | 1.63% | 477,719 | 114.70K |
| 317 | PRQR | ProQR Therapeutics N.V. | 176.98M | -5.08% | 661,081 | 18.86M |
| 318 | SLGL | Sol-Gel Technologies Ltd. | 175.48M | 8.60% | 23,562 | 18.97M |
| 319 | PLX | Protalix BioTherapeutics, Inc. | 168.88M | 1.45% | 641,210 | 61.84M |
| 320 | IPHA | Innate Pharma S.A. | 167.07M | 5.11% | 28,090 | 14.84M |
| 321 | KLRS | Kalaris Therapeutics, Inc. | 165.33M | -9.61% | 173,578 | - |
| 322 | QNCX | Quince Therapeutics, Inc. | 164.26M | 9.67% | 2,145,098 | - |
| 323 | TLSA | Tiziana Life Sciences Ltd | 162.79M | -4.20% | 285,564 | - |
| 324 | TNYA | Tenaya Therapeutics, Inc. | 159.61M | -3.58% | 1,864,486 | - |
| 325 | MOLN | Molecular Partners AG | 158.74M | 1.71% | 9,817 | 856.30K |
| 326 | NKTX | Nkarta, Inc. | 154.84M | 4.31% | 793,430 | - |
| 327 | SRZN | Surrozen, Inc. | 154.37M | -2.60% | 127,477 | 3.60M |
| 328 | CDXS | Codexis, Inc. | 151.74M | 2.44% | 359,112 | 52.93M |
| 329 | ELDN | Eledon Pharmaceuticals, Inc. | 151.56M | 10.40% | 1,249,815 | - |
| 330 | SGMO | Sangamo Therapeutics, Inc. | 151.09M | 1.35% | 4,637,560 | 32.88M |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 150.41M | -6.05% | 1,625,943 | 70.00M |
| 332 | KPTI | Karyopharm Therapeutics Inc. | 150.05M | -5.59% | 603,236 | 142.53M |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 148.04M | -3.85% | 240,027 | - |
| 334 | CRBU | Caribou Biosciences, Inc. | 147.68M | -4.82% | 2,556,486 | 9.30M |
| 335 | AGEN | Agenus Inc. | 144.54M | 8.70% | 893,876 | 106.83M |
| 336 | MCRB | Seres Therapeutics, Inc. | 143.30M | 1.21% | 96,774 | 351.00K |
| 337 | SPRO | Spero Therapeutics, Inc. | 141.41M | -1.57% | 166,863 | 40.55M |
| 338 | IRD | Opus Genetics, Inc. | 141.38M | 6.22% | 366,544 | 14.63M |
| 339 | CNTX | Context Therapeutics Inc. | 136.90M | -7.45% | 1,311,850 | - |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 136.52M | - | 179,014 | 2.00M |
| 341 | ELTX | Elicio Therapeutics, Inc. | 135.26M | -3.97% | 115,354 | - |
| 342 | ACTU | Actuate Therapeutics, Inc. | 133.65M | -6.35% | 94,833 | - |
| 343 | ACOG | Alpha Cognition Inc. | 132.41M | -6.74% | 136,147 | 7.43M |
| 344 | FBIO | Fortress Biotech, Inc. | 130.36M | -2.33% | 1,729,157 | 62.30M |
| 345 | CGTX | Cognition Therapeutics, Inc. | 129.76M | 4.26% | 719,444 | - |
| 346 | PYXS | Pyxis Oncology, Inc. | 128.26M | 17.05% | 5,824,016 | 2.82M |
| 347 | VRCA | Verrica Pharmaceuticals Inc. | 128.24M | 0.94% | 150,623 | 30.83M |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 126.15M | -5.02% | 769,612 | - |
| 349 | TTRX | Turn Therapeutics Inc. | 124.55M | -8.44% | 31,479 | - |
| 350 | FATE | Fate Therapeutics, Inc. | 123.43M | 1.90% | 1,912,441 | 7.14M |
| 351 | HYFT | MindWalk Holdings Corp. | 121.86M | -4.04% | 2,654,353 | 19.02M |
| 352 | WHWK | Whitehawk Therapeutics, Inc. | 121.12M | -2.65% | 138,078 | 14.38M |
| 353 | ARTV | Artiva Biotherapeutics, Inc. | 119.78M | 0.51% | 302,615 | 251.00K |
| 354 | CNTB | Connect Biopharma Holdings Limited | 118.79M | -1.16% | 45,799 | 762.00K |
| 355 | GNLX | Genelux Corporation | 117.36M | -5.36% | 514,221 | 8.00K |
| 356 | MGNX | MacroGenics, Inc. | 113.23M | -2.19% | 916,572 | 127.63M |
| 357 | RPTX | Repare Therapeutics Inc. | 110.79M | 1.18% | 559,452 | 11.87M |
| 358 | THAR | Tharimmune, Inc. | 109.70M | 7.89% | 392,595 | - |
| 359 | SEER | Seer, Inc. | 109.69M | - | 137,599 | 16.38M |
| 360 | OKYO | OKYO Pharma Limited | 108.32M | 4.35% | 278,782 | - |
| 361 | ONCY | Oncolytics Biotech Inc. | 106.70M | 2.47% | 1,703,278 | - |
| 362 | INO | Inovio Pharmaceuticals, Inc. | 105.80M | -1.28% | 1,784,401 | 182.34K |
| 363 | ABOS | Acumen Pharmaceuticals, Inc. | 104.19M | -4.97% | 302,503 | - |
| 364 | ANIX | Anixa Biosciences, Inc. | 104.02M | -6.51% | 433,594 | - |
| 365 | BMEA | Biomea Fusion, Inc. | 103.23M | 2.82% | 2,826,038 | - |
| 366 | CBUS | Cibus, Inc. | 102.75M | 0.80% | 231,029 | 3.79M |
| 367 | SAVA | Cassava Sciences, Inc. | 102.41M | 0.95% | 694,316 | - |
| 368 | COYA | Coya Therapeutics, Inc. | 99.39M | -2.06% | 364,725 | 3.99M |
| 369 | DTIL | Precision BioSciences, Inc. | 97.73M | 3.57% | 219,714 | 698.00K |
| 370 | STRO | Sutro Biopharma, Inc. | 96.52M | -7.36% | 157,838 | 105.65M |
| 371 | ETHZ | ETHZilla Corporation | 94.49M | 3.97% | 421,283 | 4.11M |
| 372 | VANI | Vivani Medical, Inc. | 93.38M | -3.76% | 129,305 | - |
| 373 | CSBR | Champions Oncology, Inc. | 93.32M | -0.88% | 3,565 | 58.42M |
| 374 | ANVS | Annovis Bio, Inc. | 91.43M | -5.99% | 826,411 | - |
| 375 | MREO | Mereo BioPharma Group plc | 90.28M | 14.75% | 32,113,284 | 500.00K |
| 376 | DWTX | Dogwood Therapeutics, Inc. | 89.48M | 5.61% | 116,036 | - |
| 377 | ATOS | Atossa Therapeutics, Inc. | 84.47M | 1.36% | 726,613 | - |
| 378 | KRRO | Korro Bio, Inc. | 84.19M | -5.89% | 183,626 | 7.37M |
| 379 | SPRB | Spruce Biosciences, Inc. | 83.27M | -2.74% | 40,579 | 697.00K |
| 380 | GANX | Gain Therapeutics, Inc. | 82.31M | -7.36% | 1,919,854 | - |
| 381 | PLRX | Pliant Therapeutics, Inc. | 81.73M | 0.76% | 875,408 | - |
| 382 | EXOZ | eXoZymes, Inc. | 79.60M | -1.66% | 517 | -700.00 |
| 383 | IMUX | Immunic, Inc. | 79.57M | -0.51% | 1,598,460 | - |
| 384 | ACET | Adicet Bio, Inc. | 78.93M | -2.74% | 190,076 | - |
| 385 | CALC | CalciMedica, Inc. | 78.89M | -6.41% | 115,496 | - |
| 386 | PTHS | Pelthos Therapeutics Inc. | 78.86M | -1.45% | 36,372 | 7.41M |
| 387 | COEP | Coeptis Therapeutics Holdings, Inc. | 78.78M | -3.01% | 60,450 | 501.00K |
| 388 | ALXO | ALX Oncology Holdings Inc. | 78.07M | 6.67% | 243,306 | - |
| 389 | PYPD | PolyPid Ltd. | 77.35M | 0.22% | 54,690 | - |
| 390 | XBIT | XBiotech Inc. | 77.23M | -1.05% | 23,496 | - |
| 391 | ADAG | Adagene Inc. | 74.94M | 3.92% | 156,760 | 103.20K |
| 392 | IMA | ImageneBio, Inc. | 73.92M | - | 4,124 | 800.00K |
| 393 | ENTX | Entera Bio Ltd. | 72.00M | -1.88% | 257,377 | 124.00K |
| 394 | MNOV | MediciNova, Inc. | 71.02M | -4.93% | 74,744 | 257.92K |
| 395 | KZIA | Kazia Therapeutics Limited | 70.17M | -5.57% | 147,158 | 1.20M |
| 396 | EQ | Equillium, Inc. | 70.03M | 0.88% | 646,829 | 4.39M |
| 397 | CRVO | CervoMed Inc. | 69.30M | -3.17% | 62,427 | 6.16M |
| 398 | IFRX | InflaRx N.V. | 69.10M | -1.92% | 739,276 | 73.73K |
| 399 | BYSI | BeyondSpring Inc. | 68.26M | 4.40% | 19,846 | 1.88M |
| 400 | PSTV | Plus Therapeutics, Inc. | 67.34M | -11.74% | 3,004,292 | 5.26M |
| 401 | ATYR | aTyr Pharma, Inc. | 66.92M | -4.17% | 1,219,987 | 190.00K |
| 402 | TCRX | TScan Therapeutics, Inc. | 66.40M | -3.31% | 630,706 | 8.42M |
| 403 | NRXP | NRx Pharmaceuticals, Inc. | 65.72M | - | 568,862 | 242.00K |
| 404 | MGX | Metagenomi, Inc. | 65.71M | -2.23% | 283,806 | 30.91M |
| 405 | TVGN | Tevogen Bio Holdings Inc. | 64.57M | -16.45% | 1,813,520 | - |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 62.26M | -0.85% | 244,748 | - |
| 407 | ICCC | ImmuCell Corporation | 61.24M | 4.23% | 14,769 | 27.77M |
| 408 | IBIO | iBio, Inc. | 60.72M | - | 3,354,219 | 500.00K |
| 409 | MAIA | MAIA Biotechnology, Inc. | 60.08M | -3.68% | 322,562 | - |
| 410 | ANL | Adlai Nortye Ltd. | 58.67M | -0.63% | 78,647 | -1.35M |
| 411 | ATHE | Alterity Therapeutics Limited | 58.47M | - | 8,163 | 3.57M |
| 412 | PASG | Passage Bio, Inc. | 56.93M | -9.77% | 82,372 | - |
| 413 | RADX | Radiopharm Theranostics Limited | 56.81M | - | 26,451 | 8.20M |
| 414 | INKT | MiNK Therapeutics, Inc. | 56.33M | -3.23% | 5,992 | - |
| 415 | GRCE | Grace Therapeutics, Inc. | 55.71M | -2.44% | 271,965 | - |
| 416 | NRXS | NeurAxis, Inc. | 54.86M | 5.97% | 273,448 | 3.36M |
| 417 | LITS | Lite Strategy, Inc. | 53.68M | -0.68% | 470,474 | - |
| 418 | PDSB | PDS Biotechnology Corporation | 53.63M | -8.40% | 619,263 | - |
| 419 | ALGS | Aligos Therapeutics, Inc. | 53.26M | -3.83% | 109,932 | 2.65M |
| 420 | ACRV | Acrivon Therapeutics, Inc. | 51.43M | -6.86% | 1,253,350 | - |
| 421 | NTRB | Nutriband Inc. | 51.30M | -3.43% | 28,547 | 2.28M |
| 422 | IBO | Impact BioMedical Inc. | 50.78M | -3.88% | 56,549 | 25.00K |
| 423 | OSTX | OS Therapies Incorporated | 50.71M | -7.10% | 1,092,353 | - |
| 424 | LPCN | Lipocine Inc. | 50.13M | 12.73% | 343,379 | 4.32M |
| 425 | ABVC | ABVC BioPharma, Inc. | 49.03M | -4.59% | 94,350 | 797.92K |
| 426 | TIL | Instil Bio, Inc. | 48.49M | 0.28% | 159,612 | - |
| 427 | NXTC | NextCure, Inc. | 47.36M | 1.05% | 13,823 | - |
| 428 | PTN | Palatin Technologies, Inc. | 47.18M | -5.29% | 32,347 | 8.85M |
| 429 | APLM | Apollomics, Inc. | 46.68M | -1.00% | 7,924 | 6.93M |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 46.41M | -0.74% | 96,748 | - |
| 431 | ANEB | Anebulo Pharmaceuticals, Inc. | 46.01M | -1.75% | 59,043 | - |
| 432 | KZR | Kezar Life Sciences, Inc. | 45.18M | -0.48% | 22,099 | - |
| 433 | QTTB | Q32 Bio Inc. | 44.79M | 1.11% | 123,682 | - |
| 434 | ESLA | Estrella Immunopharma, Inc. | 44.56M | -11.67% | 113,885 | - |
| 435 | OKUR | OnKure Therapeutics, Inc. | 43.49M | 2.23% | 54,285 | - |
| 436 | HURA | TuHURA Biosciences, Inc. | 43.43M | -5.09% | 221,147 | - |
| 437 | EVAX | Evaxion A/S | 43.20M | 1.97% | 52,332 | 7.65M |
| 438 | CVM | CEL-SCI Corporation | 43.14M | -6.39% | 63,313 | - |
| 439 | ATRA | Atara Biotherapeutics, Inc. | 42.40M | -56.99% | 4,620,833 | 151.93M |
| 440 | TVRD | Tvardi Therapeutics, Inc. | 42.12M | -1.32% | 143,607 | - |
| 441 | JSPR | Jasper Therapeutics, Inc. | 41.42M | -1.99% | 1,946,745 | - |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 40.55M | -6.47% | 346,871 | 90.00K |
| 443 | INMB | INmune Bio, Inc. | 39.08M | -1.34% | 416,808 | 50.00K |
| 444 | RNXT | RenovoRx, Inc. | 38.48M | -6.25% | 715,871 | 928.00K |
| 445 | GBIO | Generation Bio Co. | 38.01M | 2.92% | 78,198 | 15.27M |
| 446 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 37.98M | -4.41% | 4,885,749 | - |
| 447 | CELU | Celularity Inc. | 37.59M | 1.54% | 39,420 | 40.58M |
| 448 | LTRN | Lantern Pharma Inc. | 37.58M | -3.72% | 22,424 | - |
| 449 | XCUR | Exicure, Inc. | 37.22M | - | 36,472 | 500.00K |
| 450 | OTLK | Outlook Therapeutics, Inc. | 36.81M | -2.68% | 4,051,325 | 1.41M |
| 451 | VERU | Veru Inc. | 36.43M | -5.02% | 218,587 | 16.89M |
| 452 | IOBT | IO Biotech, Inc. | 36.41M | -10.03% | 1,211,007 | - |
| 453 | JUNS | Jupiter Neurosciences, Inc. | 35.11M | -3.77% | 57,433 | - |
| 454 | XLO | Xilio Therapeutics, Inc. | 34.99M | -1.99% | 157,485 | 31.80M |
| 455 | CING | Cingulate Inc. | 34.99M | 5.18% | 269,533 | - |
| 456 | GLTO | Galecto, Inc. | 34.81M | 6.44% | 28,102 | - |
| 457 | DYAI | Dyadic International, Inc. | 33.55M | -2.40% | 10,802 | 3.34M |
| 458 | GNTA | Genenta Science S.p.A. | 32.57M | -2.11% | 77,427 | - |
| 459 | CUE | Cue Biopharma, Inc. | 31.48M | -4.30% | 902,341 | 7.10M |
| 460 | ANTX | AN2 Therapeutics, Inc. | 31.24M | -12.31% | 172,662 | - |
| 461 | BRNS | Barinthus Biotherapeutics plc | 31.03M | 0.07% | 49,514 | 14.97M |
| 462 | RLYB | Rallybio Corporation | 30.67M | 2.24% | 153,057 | 674.00K |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 30.59M | -3.74% | 373,928 | - |
| 464 | MRKR | Marker Therapeutics, Inc. | 30.51M | -8.50% | 249,023 | 4.69M |
| 465 | RNTX | Rein Therapeutics Inc. | 30.23M | -1.71% | 135,329 | - |
| 466 | SKYE | Skye Bioscience, Inc. | 30.17M | -3.97% | 314,325 | - |
| 467 | LIXT | Lixte Biotechnology Holdings, Inc. | 29.62M | -6.85% | 66,768 | - |
| 468 | SNTI | Senti Biosciences, Inc. | 29.45M | 0.90% | 302,861 | - |
| 469 | HYPD | Hyperion DeFi, Inc. | 29.40M | 5.15% | 279,767 | 345.32K |
| 470 | PLUR | Pluri Inc. | 28.88M | 2.62% | 8,565 | 1.33M |
| 471 | IGC | IGC Pharma, Inc. | 28.74M | -0.13% | 347,948 | 1.11M |
| 472 | HOWL | Werewolf Therapeutics, Inc. | 27.89M | -4.79% | 544,377 | 1.14M |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 27.80M | 6.64% | 1,945,994 | 721.00K |
| 474 | BOLD | Boundless Bio, Inc. | 27.76M | -5.34% | 160,423 | - |
| 475 | DARE | Daré Bioscience, Inc. | 27.72M | -2.02% | 59,042 | -57.13K |
| 476 | PLRZ | Polyrizon Ltd. | 27.12M | 7.43% | 76,161 | - |
| 477 | QNTM | Quantum BioPharma Ltd. | 27.04M | 0.43% | 40,031 | - |
| 478 | ATHA | Athira Pharma, Inc. | 26.62M | - | - | - |
| 479 | SER | Serina Therapeutics, Inc. | 26.34M | -2.76% | 45,637 | 116.00K |
| 480 | FBLG | FibroBiologics, Inc. | 25.63M | 13.99% | 1,379,723 | - |
| 481 | INTS | Intensity Therapeutics, Inc. | 24.76M | -0.79% | 617,960 | - |
| 482 | KLTO | Klotho Neurosciences, Inc. | 24.58M | 0.21% | 176,493 | - |
| 483 | NNVC | NanoViricides, Inc. | 24.37M | 0.89% | 245,359 | - |
| 484 | NEUP | Neuphoria Therapeutics Inc. | 22.58M | 0.24% | 47,948 | 15.65M |
| 485 | CASI | CASI Pharmaceuticals, Inc. | 22.19M | -1.82% | 58,420 | 26.85M |
| 486 | LNAI | Lunai Bioworks Inc. | 22.10M | -1.74% | 98,496 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 20.90M | -2.82% | 144,457 | - |
| 488 | LIMN | Liminatus Pharma, Inc. | 20.84M | 6.06% | 73,626 | - |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 19.94M | 4.41% | 105,441 | - |
| 490 | ALLR | Allarity Therapeutics, Inc. | 19.80M | -2.56% | 132,808 | - |
| 491 | CLGN | CollPlant Biotechnologies Ltd. | 19.29M | 2.72% | 10,127 | 2.48M |
| 492 | LEXX | Lexaria Bioscience Corp. | 19.16M | 3.20% | 235,699 | 705.92K |
| 493 | VYNE | VYNE Therapeutics Inc. | 18.64M | -1.70% | 303,223 | 524.00K |
| 494 | BCAB | BioAtla, Inc. | 18.58M | -12.63% | 1,970,427 | 11.00M |
| 495 | LSTA | Lisata Therapeutics, Inc. | 18.40M | 5.89% | 34,776 | 1.07M |
| 496 | OSRH | OSR Holdings, Inc. | 18.40M | 8.26% | 39,657,843 | -90.52K |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 18.37M | -0.35% | 349,079 | - |
| 498 | KAPA | Kairos Pharma, Ltd. | 18.32M | -0.02% | 46,655 | - |
| 499 | PMN | ProMIS Neurosciences, Inc. | 18.27M | 4.43% | 11,701 | - |
| 500 | KALA | KALA BIO, Inc. | 18.08M | 1.35% | 278,949 | - |
| 501 | MTVA | MetaVia Inc. | 17.98M | 0.15% | 12,763 | - |
| 502 | ITRM | Iterum Therapeutics plc | 17.31M | - | 878,247 | 390.00K |
| 503 | HOTH | Hoth Therapeutics, Inc. | 16.60M | -0.93% | 141,449 | - |
| 504 | CLRB | Cellectar Biosciences, Inc. | 16.11M | 23.38% | 1,154,922 | - |
| 505 | COCP | Cocrystal Pharma, Inc. | 15.30M | -2.63% | 109,778 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.20M | -0.89% | 12,895,657 | 1.00M |
| 507 | BCDA | BioCardia, Inc. | 15.07M | 1.07% | 70,603 | 3.00K |
| 508 | BCTX | BriaCell Therapeutics Corp. | 14.45M | 5.38% | 73,404 | - |
| 509 | SNSE | Sensei Biotherapeutics, Inc. | 14.40M | -1.68% | 30,385 | - |
| 510 | GDTC | CytoMed Therapeutics Limited | 14.31M | -6.06% | 19,314 | 573.19K |
| 511 | TPST | Tempest Therapeutics, Inc. | 14.09M | -1.04% | 25,667 | - |
| 512 | SNGX | Soligenix, Inc. | 13.82M | 1.48% | 165,618 | 2.34K |
| 513 | NCNA | NuCana plc | 13.73M | -2.08% | 48,845 | - |
| 514 | GRDX | GridAI Technologies Corp. | 13.62M | -13.28% | 174,384 | - |
| 515 | BLRX | BioLineRx Ltd. | 13.25M | -1.85% | 7,983 | 12.74M |
| 516 | SYBX | Synlogic, Inc. | 13.10M | -1.75% | 3,054 | 8.00K |
| 517 | AEON | AEON Biopharma, Inc. | 13.03M | 1.90% | 139,494 | - |
| 518 | PHIO | Phio Pharmaceuticals Corp. | 12.81M | 2.59% | 241,386 | - |
| 519 | AKTX | Akari Therapeutics, Plc | 12.59M | -2.38% | 358,794 | - |
| 520 | MBRX | Moleculin Biotech, Inc. | 12.47M | 1.76% | 145,634 | - |
| 521 | EDSA | Edesa Biotech, Inc. | 12.25M | -2.00% | 2,754 | - |
| 522 | LGVN | Longeveron Inc. | 12.20M | -8.25% | 296,958 | 1.44M |
| 523 | IMNN | Imunon, Inc. | 12.11M | -3.52% | 45,753 | - |
| 524 | CRIS | Curis, Inc. | 11.83M | 10.67% | 1,569,388 | 11.65M |
| 525 | NCEL | NewcelX Ltd. | 11.35M | 13.70% | 2,236,887 | - |
| 526 | CMMB | Chemomab Therapeutics Ltd. | 11.26M | 2.23% | 79,892 | - |
| 527 | BOLT | Bolt Biotherapeutics, Inc. | 11.15M | -0.34% | 13,234 | 5.20M |
| 528 | ABP | Abpro Holdings, Inc. | 10.65M | -2.97% | 6,243 | 183.00K |
| 529 | BRTX | BioRestorative Therapies, Inc. | 10.34M | -2.51% | 7,730 | 383.40K |
| 530 | ASBP | Aspire Biopharma Holdings, Inc. | 10.21M | -8.65% | 25,005,894 | 1.94K |
| 531 | ERNA | Ernexa Therapeutics Inc. | 10.20M | -0.76% | 27,672 | 1,000.00 |
| 532 | TRAW | Traws Pharma, Inc. | 10.15M | -5.22% | 142,088 | 2.85M |
| 533 | INAB | IN8bio, Inc. | 10.10M | -7.23% | 99,377 | - |
| 534 | EVGN | Evogene Ltd. | 9.90M | -2.70% | 18,035 | 8.02M |
| 535 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.83M | -4.03% | 14,646 | - |
| 536 | BIVI | BioVie Inc. | 9.50M | -0.79% | 72,541 | - |
| 537 | PMCB | PharmaCyte Biotech, Inc. | 9.10M | 1.87% | 303,435 | - |
| 538 | ALZN | Alzamend Neuro, Inc. | 8.86M | -2.51% | 19,344 | - |
| 539 | PULM | Pulmatrix, Inc. | 8.58M | -0.42% | 19,800 | 3.00K |
| 540 | APM | Aptorum Group Limited | 8.47M | -0.95% | 23,843 | - |
| 541 | APVO | Aptevo Therapeutics Inc. | 8.40M | -7.14% | 92,161 | - |
| 542 | ADXN | Addex Therapeutics Ltd | 8.34M | 2.24% | 144 | 198.82K |
| 543 | ICU | SeaStar Medical Holding Corporation | 8.29M | 1.77% | 97,313 | 881.00K |
| 544 | CLDI | Calidi Biotherapeutics, Inc. | 8.19M | -2.63% | 205,513 | - |
| 545 | MBIO | Mustang Bio, Inc. | 8.10M | -4.31% | 34,560 | - |
| 546 | KPRX | Kiora Pharmaceuticals, Inc. | 7.96M | 0.93% | 10,770 | 20.00K |
| 547 | TOVX | Theriva Biologics, Inc. | 7.77M | 1.49% | 884,370 | - |
| 548 | GTBP | GT Biopharma, Inc. | 7.76M | 7.83% | 964,741 | - |
| 549 | IMRN | Immuron Limited | 7.44M | 14.51% | 287,351 | 4.78M |
| 550 | RNAZ | TransCode Therapeutics, Inc. | 7.29M | -0.75% | 23,867 | - |
| 551 | CELZ | Creative Medical Technology Holdings, Inc. | 7.16M | -8.89% | 132,984 | 6.00K |
| 552 | PCSA | Processa Pharmaceuticals, Inc. | 7.11M | -6.55% | 39,853 | - |
| 553 | PPBT | Purple Biotech Ltd | 7.07M | -1.62% | 70,287 | - |
| 554 | SLXN | Silexion Therapeutics Corp | 6.63M | - | 16,386 | - |
| 555 | XTLB | XTL Biopharmaceuticals Ltd. | 6.60M | -0.99% | 18,238 | 968.00K |
| 556 | APRE | Aprea Therapeutics, Inc. | 6.54M | -1.08% | 24,196 | 488.24K |
| 557 | ACXP | Acurx Pharmaceuticals, Inc. | 6.53M | -5.12% | 23,368 | - |
| 558 | CYCN | Cyclerion Therapeutics, Inc. | 6.51M | 3.64% | 199,736 | 2.86M |
| 559 | ADIL | Adial Pharmaceuticals, Inc. | 6.47M | -3.72% | 275,302 | - |
| 560 | BGMS | Bio Green Med Solution, Inc. | 6.37M | -5.11% | 60,165 | 81.00K |
| 561 | TCRT | Alaunos Therapeutics, Inc. | 6.36M | -9.52% | 45,211 | 6.00K |
| 562 | GOVX | GeoVax Labs, Inc. | 6.13M | - | 477,797 | 3.35M |
| 563 | PPCB | Propanc Biopharma, Inc. | 6.06M | -1.97% | 61,349 | - |
| 564 | GNPX | Genprex, Inc. | 6.03M | 18.18% | 3,669,567 | - |
| 565 | INDP | Indaptus Therapeutics, Inc. | 5.52M | 0.64% | 110,052 | - |
| 566 | CANF | Can-Fite BioPharma Ltd. | 5.48M | 2.66% | 47,917 | 560.00K |
| 567 | REVB | Revelation Biosciences, Inc. | 5.33M | - | 52,116 | - |
| 568 | VIVS | VivoSim Labs, Inc. | 5.27M | 5.21% | 50,074 | 140.00K |
| 569 | SILO | Silo Pharma, Inc. | 5.26M | 0.66% | 80,208 | 72.10K |
| 570 | XBIO | Xenetic Biosciences, Inc. | 5.26M | 4.08% | 15,775 | 2.86M |
| 571 | DCOY | Decoy Therapeutics Inc. | 5.20M | -0.59% | 131,459 | - |
| 572 | SPRC | SciSparc Ltd. | 4.75M | -0.68% | 28,037 | 1.31M |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.58M | 0.30% | 35,745 | - |
| 574 | MTNB | Matinas BioPharma Holdings, Inc. | 4.16M | 0.98% | 37,074 | - |
| 575 | XRTX | XORTX Therapeutics Inc. | 4.01M | -0.74% | 9,389 | - |
| 576 | ENVB | Enveric Biosciences, Inc. | 3.91M | -3.54% | 48,026 | - |
| 577 | JAGX | Jaguar Health, Inc. | 3.77M | -20.95% | 28,601,233 | 11.79M |
| 578 | CNSP | CNS Pharmaceuticals, Inc. | 3.73M | 3.26% | 12,552 | - |
| 579 | LYRA | Lyra Therapeutics, Inc. | 3.66M | -45.31% | 422,384 | 600.00K |
| 580 | OGEN | Oragenics, Inc. | 3.58M | 3.45% | 41,592 | - |
| 581 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.54M | -5.37% | 118,691 | 15.78K |
| 582 | PHGE | BiomX Inc. | 3.43M | -1.32% | 42,070 | - |
| 583 | HCWB | HCW Biologics Inc. | 3.30M | - | 18,794 | 422.03K |
| 584 | ENSC | Ensysce Biosciences, Inc. | 3.29M | -11.26% | 158,357 | 4.49M |
| 585 | AZTR | Azitra, Inc. | 3.28M | 5.24% | 2,219,373 | 7.50K |
| 586 | CMND | Clearmind Medicine Inc. | 3.24M | -8.09% | 53,497 | - |
| 587 | BBLG | Bone Biologics Corporation | 2.96M | 1.85% | 19,708 | - |
| 588 | ARTL | Artelo Biosciences, Inc. | 2.83M | -1.41% | 48,332 | - |
| 589 | SCNI | Scinai Immunotherapeutics Ltd. | 2.70M | 2.19% | 3,808 | 1.15M |
| 590 | CDT | CDT Equity Inc. | 2.55M | -2.65% | 45,968 | - |
| 591 | VRAX | Virax Biolabs Group Limited | 2.54M | -5.52% | 135,306 | 2.99K |
| 592 | ONCO | Onconetix, Inc. | 2.49M | -6.98% | 56,663 | 1.22M |
| 593 | GRI | GRI Bio, Inc. | 2.45M | 7.56% | 1,799,962 | - |
| 594 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.42M | 8.47% | 441,562 | 1.36M |
| 595 | DRMA | Dermata Therapeutics, Inc. | 2.14M | -12.50% | 146,570 | - |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.95M | -0.85% | 79,066 | 104.90K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.49M | -0.66% | 315,414 | - |
| 598 | ADTX | Aditxt, Inc. | 1.45M | 3.14% | 214,732 | 5.95K |
| 599 | MLEC | Moolec Science SA | 1.10M | -2.38% | 24,445 | 7.83M |
| 600 | ELAB | PMGC Holdings Inc. | 980.38K | 0.38% | 99,508 | 285.95K |